share_log

Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Moshe Arkin(10.15%)

Eiger BioPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Moshe Arkin(10.15%)

美股sec公告 ·  2023/04/18 09:59
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息